Evidence map›Paper›PMID 33854984›Full record

ArticleFrontiers in cellular and infection microbiology2021

Zhangchun Guan, Yu Liu, Chenghua Liu, Huiting Wang, Jiannan Feng, Guang Yang

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.0field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Review
  3. Anti-staphylococcal activity of the auranofin-analogous PEtFrontiers in cellular and infection microbiology · 2026
    Article
  4. Article
  5. Virulence · 2025
    Article
  6. Modulation of NK Cell Properties by ESKAPE Group Bacteria.International journal of molecular sciences · 2025
    Article
  7. Review
  8. Article
  9. Pathogens (Basel, Switzerland) · 2025
    Review
  10. Frontiers in immunology · 2025
    Article
  11. Article
  12. Microbiology spectrum · 2024
    Article
  13. Article
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Zhangchun GuanBeijing Institute of Pharmacology and Toxicology, Beijing, China.
Yu LiuBeijing Institute of Pharmacology and Toxicology, Beijing, China.
Chenghua LiuBeijing Institute of Pharmacology and Toxicology, Beijing, China.
Huiting WangBeijing Institute of Pharmacology and Toxicology, Beijing, China.
Jiannan FengBeijing Institute of Pharmacology and Toxicology, Beijing, China.
Guang YangBeijing Institute of Pharmacology and Toxicology, Beijing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

IFN-γ is produced upon stimulation with

Indexed as

Leukocytes, MononuclearStaphylococcus aureusCD56 AntigenHemolysin ProteinsHumansInterferon-gammaKiller Cells, NaturalSphingomyelin PhosphodiesteraseCD56 AntigenHemolysin ProteinsInterferon-gammaNCAM1 protein, humanSphingomyelin PhosphodiesterasecalciumCD56bright NK cellsERKIFN-γS. aureusβ-hemolysin

Identifiers

PMID33854984
PMCPMC8039520
OpenAlexW3151842522

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.